Lynparza in combination with Abiraterone and Prednisone approved in the EU as treatment for metastatic castration-resistant prostate cancer
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
This digital linking of individual’s health records with ABHA is being carried out extensively across different health facilities of the country
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
The investment will enable the company to enter European markets as well as enhance margins in current markets
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
They also released the Operational Guidelines for Wellness activities at AB-HWCs
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
The use of procalcitonin testing for sepsis management is highest in the US
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
Subscribe To Our Newsletter & Stay Updated